Ajanta Pharma (NSE:AJANTPHARM, BOM:532331) has received five observations from the US FDA concluded an inspection at our manufacturing facility at Paithan in Maharashtra, India, according to a filing to the Indian stock exchanges.
The regulator inspected the facility from April 13 to 21 and closed with the issuance of Form-483 with five observations.
The company said it will respond to the U.S. FDA within the stipulated timeline.
The company's shares were down nearly 1% in recent trade.
China Minsheng Banking (SHA:600016, HKG:1988) issued Tier 2 capital bonds amounting to 30 billion yuan, according to a Shanghai bourse filing on Wednesday.The 10-year fixed-rate bonds have a coupon rate of 2.13%, with a conditional issuer call option at the end of the fifth year.Proceeds from the issuance will be used to supplement the lender's Tier 2 capital.The bank's Hong Kong shares slipped 1% during the morning trade.
Kaishan Group (SHE:300257) posted 2025 attributable net profit of 364.2 million yuan, up 14% from 320.4 million yuan the previous year.Earnings per share rose to 0.37 yuan from 0.32 yuan, according to a Wednesday filing with the Shenzhen bourse.The compressor maker's operating revenue rose 12% year over year to 4.72 billion yuan from 4.23 billion yuan.Shares of the company were down 1% in recent trade.
Shanjin International Gold's (SHE:000975) attributable profit rose 101% to 1.39 billion yuan in the first quarter from 693.8 million yuan in the year-ago period, according to a Wednesday filing with the Shenzhen bourse.Earnings per share at the mining company increased 101% to 0.5023 yuan from 0.2499 yuan in the prior-year period.Operating income grew 37% year over year to 5.94 billion yuan from 4.32 billion yuan.Shares increased 1% during the midday break on Wednesday.